GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Chordate Medical Holding AB (FRA:K1Z) » Definitions » Market Cap

Chordate Medical Holding AB (FRA:K1Z) Market Cap : €1.31 Mil (As of Apr. 03, 2025)


View and export this data going back to 2022. Start your Free Trial

What is Chordate Medical Holding AB Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Chordate Medical Holding AB's share price for the quarter that ended in Sep. 2024 was €2.13729. Chordate Medical Holding AB's Shares Outstanding (EOP) for the quarter that ended in Sep. 2024 was 1.03 Mil. Therefore, Chordate Medical Holding AB's market cap for the quarter that ended in Sep. 2024 was €2.20 Mil.

Chordate Medical Holding AB's quarterly market cap increased from Mar. 2024 (€0.05 Mil) to Jun. 2024 (€1.86 Mil) and increased from Jun. 2024 (€1.86 Mil) to Sep. 2024 (€2.20 Mil).

Chordate Medical Holding AB's annual market cap increased from Dec. 2021 (€0.00 Mil) to Dec. 2022 (€1.94 Mil) and increased from Dec. 2022 (€1.94 Mil) to Dec. 2023 (€2.15 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Chordate Medical Holding AB's Enterprise Value for Today is €0.90 Mil.


Chordate Medical Holding AB Market Cap Historical Data

The historical data trend for Chordate Medical Holding AB's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chordate Medical Holding AB Market Cap Chart

Chordate Medical Holding AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial Premium Member Only - - - 1.94 2.15

Chordate Medical Holding AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.92 2.15 0.05 1.86 2.20

Competitive Comparison of Chordate Medical Holding AB's Market Cap

For the Medical Devices subindustry, Chordate Medical Holding AB's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chordate Medical Holding AB's Market Cap Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Chordate Medical Holding AB's Market Cap distribution charts can be found below:

* The bar in red indicates where Chordate Medical Holding AB's Market Cap falls into.


;
;

Chordate Medical Holding AB Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Chordate Medical Holding AB's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=€3.34549*0.643
=€2.15

Chordate Medical Holding AB's Market Cap for the quarter that ended in Sep. 2024 is calculated as

Market Cap (Q: Sep. 2024 )=Share Price (Q: Sep. 2024 )*Shares Outstanding (EOP) (Q: Sep. 2024 )
=€2.13729*1.030
=€2.20

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Chordate Medical Holding AB  (FRA:K1Z) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Chordate Medical Holding AB Market Cap Related Terms

Thank you for viewing the detailed overview of Chordate Medical Holding AB's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Chordate Medical Holding AB Business Description

Traded in Other Exchanges
Address
c/o Regus, Kistagangen 20B, Kista, SWE, 164 40
Chordate Medical Holding AB is a medical technology company that has developed patented and CE-marked a new nerve-modulating treatment technology for chronic nasal congestion and chronic migraine. The company sells its products in Selected European markets, Israel, and Saudi Arabia. The company's product range is based on the CE-marked treatment units Chordate System S100 and S120 for rhinitis and S220 for migraine, registered for the indications of preventive treatment of chronic migraine and chronic rhinitis and use on patients. The company sells its product system, including treatments, through distributors to clinics and hospitals in its primary markets.

Chordate Medical Holding AB Headlines

No Headlines